BRADY KING

NVG, LLC · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

4 agencies contacted

Activity

filings by quarter

Works on

Health Issues 10 Medicare/Medicaid 9 Budget/Appropriations 7 Defense 6 Accounting 3 Computer Industry 3 Banking 3 Science/Technology 3 Copyright/Patent/Trademark 3 Veterans 2 Government Issues 2 Law Enforcement/Crime/Criminal Justice 1 Labor Issues/Antitrust/Workplace 1 Homeland Security 1 Aviation/Airlines/Airports 1

Background

Government experience

Chief of Staff

Rep Kendra Horn; Chief of Staff, Sen Roland Burris; Chief of Staff, Rep Tim Mahoney; LD, Rep Allen Boyd; National Security Advisor, Sen Edward Kennedy; National Security Advisor, Sen Mark Dayton; Approps Associate, Rep Chet Edwards

Disclosed on LD-2 filings

Career

NVG, LLC

Washington, DC

2024 - present

Specific issues

Issues related to the home care workforce. Issues related to nursing home staffing. Issues related to dialysis. H.R.6860/S.5018 - Restore Protections for Dialysis Patients Act. CMS final rule: Minimum Staffing Standards for Long Term Care Facilities and Medicaid Institutional Payment Transparency Reporting. CMS final rule: Ensuring Access to Medicaid Services. Congressional Review Act resolution to overturn minimum staffing standards for long term care facilities final rule.

Medicare/Medicaid · 2024 Q3

340B legislation. Issues related to vaccine injury compensation funds. S.2115/H.R.4307 - Medical Supply Chain Resiliency Act.

Health Issues · 2024 Q3

Intellectual property, data exclusivity, and patent eligibility.

Issues related to Pandemics and All Hazards Preparedness Act (PAHPA) Reauthorization.

Health Issues · 2024 Q3

Issues related to competitive bidding for Durable Medical Equipment. S.1294 - Competitive Bidding Relief Act of 2023. H.R.5555 - DMEPOS Relief Act 2023. H.R.7829/S.3821 - SOAR Act of 2024.

Medicare/Medicaid · 2024 Q3

Issues related to domestic production and acquisition of medical personal protective equipment (PPE).

Defense · 2024 Q3